Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) Gross Profit: 2019-2024

Historic Gross Profit for Eton Pharmaceuticals (ETON) over the last 6 years, with Dec 2024 value amounting to $23.4 million.

  • Eton Pharmaceuticals' Gross Profit rose 24.64% to $7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.1 million, marking a year-over-year increase of 75.62%. This contributed to the annual value of $23.4 million for FY2024, which is 11.16% up from last year.
  • Latest data reveals that Eton Pharmaceuticals reported Gross Profit of $23.4 million as of FY2024, which was up 11.16% from $21.1 million recorded in FY2023.
  • In the past 5 years, Eton Pharmaceuticals' Gross Profit registered a high of $23.4 million during FY2024, and its lowest value of -$247,000 during FY2020.
  • For the 3-year period, Eton Pharmaceuticals' Gross Profit averaged around $19.6 million, with its median value being $21.1 million (2023).
  • In the last 5 years, Eton Pharmaceuticals' Gross Profit crashed by 148.81% in 2020 and then spiked by 7,794.33% in 2021.
  • Eton Pharmaceuticals' Gross Profit (Yearly) stood at -$247,000 in 2020, then soared by 7,794.33% to $19.0 million in 2021, then dropped by 24.66% to $14.3 million in 2022, then soared by 47.09% to $21.1 million in 2023, then increased by 11.16% to $23.4 million in 2024.